Ion Beam Applications SA (OTCMKTS:IOBCF – Get Free Report) was the recipient of a large drop in short interest during the month of February. As of February 27th, there was short interest totaling 1,221 shares, a drop of 50.6% from the February 12th total of 2,471 shares. Based on an average trading volume of 0 shares, the days-to-cover ratio is currently ∞ days. Based on an average trading volume of 0 shares, the days-to-cover ratio is currently ∞ days.
Ion Beam Applications Stock Performance
IOBCF stock opened at $16.85 on Friday. The company’s 50 day moving average is $17.28 and its 200 day moving average is $15.06. Ion Beam Applications has a 1-year low of $10.15 and a 1-year high of $19.00.
About Ion Beam Applications
Ion Beam Applications (OTCMKTS: IOBCF) is a Belgium-based medical technology company specializing in the development and deployment of particle therapy solutions for cancer treatment. Founded in 1986 and headquartered in Louvain-la-Neuve, the company is best known for its Proteus® line of proton therapy systems, which are designed to deliver precise, high-energy particle beams that target tumors while sparing healthy tissue. IBA oversees the full project lifecycle, from system design and manufacturing to installation, commissioning, and ongoing service support.
In addition to its flagship proton therapy business, IBA operates a diversified portfolio of technologies for medical and industrial applications.
Featured Stories
- Five stocks we like better than Ion Beam Applications
- The gold chart Wall Street is terrified of…
- Elon Musk already made me a “wealthy man”
- Unlocked: Elon Musk’s Next Big IPO
- 1,500 Banks Just Handed the Fed Your Bank Account
- Silver paying 20% dividend. Plus 68% share gains
Receive News & Ratings for Ion Beam Applications Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ion Beam Applications and related companies with MarketBeat.com's FREE daily email newsletter.
